Q3 2019 X4 Pharmaceuticals Inc Earnings Call Transcript
Greetings and welcome to X4 Pharmaceuticals Third Quarter 2019 Financial Results and Business Update Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded.
It is now my pleasure to introduce your host, Stephanie Carrington, Managing Direction of Investor Relations at Westwicke. You may begin.
Thank you, Operator. Good morning, everyone, and welcome to X4 Pharmaceuticals Third Quarter 2019 Financial Results and Business Update Conference Call.
I'm joined today by X4 Pharmaceuticals Chief Executive Office, Dr. Paula Ragan; Chief Medical Officer, Dr. Lynne Kelley; and Chief Financial Officer, Adam Mostafa.
Now turning to today's call, Paula will provide an overview of recent developments, Lynne will discuss clinical development progress, and Adam will recap the financial results for the third quarter. We will then open the call to your questions.
But before we begin, I would like to remind you that X4 will be
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |